Head and Neck Paragangliomas: A 16-year Experience of a University Hospital in Turkey

The aim of the study is to examine the head and neck paraganglioma cases treated in Pamukkale University hospital between 2007-2023 and improve our understanding of these cases and contribute to the knowledge surrounding head and neck paragangliomas.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Head and Neck Paraganglioma Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Paraganglioma

Sex eligibility

All sexes

Study type

Observational

Primary location

Pamukkale University

Denizli, 20070, Turkey (Türkiye)

About this study

39 patients were selected and analyzed retrospectively. Demographic informations, complaints at the time of admission, radiological examinations, paraganglioma types, stages, postoperative complications, and relapsed cases were recorded.Preoperative staging plays a crucial role in surgical planning and predicting potential intraoperative complications. In such cases, combination therapy alongside surgery may improve treatment outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Histopathological diagnosis of carotid paraganglioma
Histopathological diagnosis of vagal paraganglioma
Histopathological diagnosis of jugular paraganglioma
Histopathological diagnosis of tympanic paraganglioma

Exclusion criteria

-Inadequate information in files

Treatment and study plan

Primary outcomes

Postoperative recurrence

Time frame: may 2023-june 2023

Incidence of recurrences after the surgery
Postoperative nerve paralysis

Time frame: may 2023-june 2023

Incidence of facial, vagus, hypoglossus, accesorius nerve paralysis after surgery

Sponsors and collaborators

Lead sponsor

Pamukkale University

Other

Registry information

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Jul 12, 2023
Registry last updated: Sep 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed